Bruker's eXtreme Resolution Magnetic Resonance Mass Spectrometry (MRMS) technology enables scientists to see vital "hidden" information that is missing in data from other types of mass spectrometers. This advanced technology addresses the needs of specialists in a variety of focus areas that all desire efficient and precise solutions for their analytical problems. The unique value of this technology is Isotopic Fine Structure (IFS), resulting in unmatched confidence for compound identification that previously required guesswork.
MRMS offers unrivaled mass resolving power and outstanding mass accuracy in the ppb range. This results in high resolution MALDI imaging data with the ability of straightforward identification of compounds from tissue directly with utmost confidence. Label-free molecular visualization is an enormous advantage in comparison to radioactive labeling procedures, such as whole-body autoradiography.
Molecular Drug Imager is a complete solution for label-free distribution monitoring of drug candidates and multi-generational metabolites. In silico metabolite prediction interfaces with MALDI Imaging results from 7T solariX XR for automated mapping of reactive metabolites. Uncover new biochemical pathways by utilizing the broadband detection capabilities of 7T solariX XR to correlate distributions of drug-related material with changes in endogenous compounds or histopathology.
Molecular Drug Imager